Application Information

This drug has been submitted to the FDA under the reference 020685/001.

Names and composition

"CRIXIVAN" is the commercial name of a drug composed of INDINAVIR SULFATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
020685/001 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 400MG BASE
020685/003 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 200MG BASE
020685/005 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 333MG BASE
020685/006 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 100MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020685/001 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 400MG BASE
020685/003 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 200MG BASE
020685/005 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 333MG BASE
020685/006 CRIXIVAN INDINAVIR SULFATE CAPSULE/ORAL EQ 100MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved